Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01876212
Title Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hussein Tawbi
Indications

melanoma

Therapies

Dasatinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field